<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:department>School of Life Sciences</gtr:department><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/6D93C4B4-6A1A-4858-8A69-03438AAFF1FC"><gtr:id>6D93C4B4-6A1A-4858-8A69-03438AAFF1FC</gtr:id><gtr:firstName>Chris</gtr:firstName><gtr:surname>Denning</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/6193783C-53EE-49CE-BD1B-0C41A6F978ED"><gtr:id>6193783C-53EE-49CE-BD1B-0C41A6F978ED</gtr:id><gtr:firstName>Stephen</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Hill</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FE006159%2F1"><gtr:id>54B7CF74-82BA-4D04-91CE-F2E7DB038351</gtr:id><gtr:title>A novel system for perfusion and real-time analysis of single hESC-derived cardiomyocytes</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/E006159/1</gtr:grantReference><gtr:abstractText>About one week after fertilization between egg and sperm, the cells of the developing human embryo are primed to start forming all the cell types in the body. Scientists have shown that cells can be isolated at this early stage of development and then grown in the laboratory to produce large numbers of human embryonic stem cells (hESCs). Even in the laboratory, these cells can also be induced to make all cell types in the body. This may provide new opportunities to study early human development, understand more about genetic disorders or provide new sources of transplantable cells for conditions such as cardiovascular or Parkinsons disease. While hESCs could potentially have significant impact on our understanding of developmental biology and treatment of disease, the cell types derived from hESCs have not been studied in detail. For example, beating heart cells (cardiomyocytes) have been produced from hESCs but at best only limited information is available as to how they respond to different drugs or to the effect disruption of specific genes may have. Equally, no-one knows whether the characteristics of hESC-cardiomyocytes produced one day will be comparable to those produced the next. We have demonstrated that sufficient numbers of hESC-derived cardiomyocytes can be produced for detailed analysis. We now aim to engineer a new system that can simultaneously administer and analyze the effect of a variety of cardioactive drugs / gene modulatory agents. This will enable rapid development of hESC-cardiomyocytes as a tool for understanding human development and disease, as well as providing a platform to evaluate the utility of these cells for future medical application.</gtr:abstractText><gtr:technicalSummary>Although many labs can successfully culture and spontaneously differentiate human embryonic stem cells (hESCs), the fundamental biology of undifferentiated and differentiated cells is poorly understood. To develop hESCs as scientific and therapeutic modalities, it will be vital to functionally characterize the differentiated cell types, preferably at the single cell level, to ensure reproducible preparations can be made. Thus, the aim of this proposal is to establish a platform technology to evaluate whether cohorts of single hESC-cardiomyocytes of comparable function can be produced both from different preparations using the same hESC line and from preparations using independently-derived lines Recently, we have standardized culture and cardiac differentiation between three independently-derived hESC lines, HUES-7, BG01 and NOTT1. We have now developed a high throughput differentiation protocol that utilizes growth factor induction to rapidly generate up to 45% spontaneously beating embryoid bodies (EBs). Beating areas can be readily disaggregated to single beating cardiomyocytes that are amenable to electrophysiology, calcium imaging and video edge detection, thus providing outputs to measure cardiomyocyte function and response In this proposal, we have designed and will engineer a semi-automated perfusion system that will interface with Multi Electrode Array, video edge and single cell fluorecence detection equipment to produce simultaneous real-time readouts for electrical and contractile activity, and fluorescence. This will facilitate rapid evaluation of functionality and reproducibility of different hESC-cardiomyocyte preparations as well as responsiveness to challenge with chronotropic agents. Finally, we will provide proof of principle that the system is amenable to delivery of lentiviral vectors designed for gene overexpression or knockdown in hESC-cardiomyocytes, thus establishing a novel route to studying gene function within these cells</gtr:technicalSummary><gtr:fund><gtr:end>2008-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2006-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>95223</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Observer &amp; Guardian on Sunday 2014</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>9A4C89F7-B045-46EE-9756-979A9654C539</gtr:id><gtr:impact>Description of research to National newspapers

follow up enquiries and public engagement</gtr:impact><gtr:outcomeId>545b876b09d0d6.40854822</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>2500000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF Centre for Regen Med</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:fundingRef>P47352/</gtr:fundingRef><gtr:id>CA3997F7-E660-4337-BFCA-565D468D444C</gtr:id><gtr:outcomeId>545a67552211c3.59015186</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>250000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Asha E-term fellowship</gtr:description><gtr:end>2015-11-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:id>BE06919E-7567-41A5-A421-A9D6A5957466</gtr:id><gtr:outcomeId>545a66b7837f10.39264252</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NC3Rs-CRACK-IT phase 2</gtr:description><gtr:end>2018-01-02</gtr:end><gtr:fundingOrg>National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs)</gtr:fundingOrg><gtr:id>EF59204F-7182-4902-B61A-A4197F132CC3</gtr:id><gtr:outcomeId>545a681e0ba047.28266204</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>115000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EPSRC equip - seahorse</gtr:description><gtr:end>2015-03-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:id>41040C39-1BDF-42F0-A173-8A98C42B6911</gtr:id><gtr:outcomeId>545a67ec910b43.40227873</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>714000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC capital equipment</gtr:description><gtr:end>2014-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/L012618/1</gtr:fundingRef><gtr:id>172515ED-74E4-40D4-842E-DE9ECE12D3FE</gtr:id><gtr:outcomeId>545a67134da282.80690766</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1125000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF programme 2014-17</gtr:description><gtr:end>2017-04-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>F179A5D4-06CA-4353-BC29-F7BF0CE42048</gtr:id><gtr:outcomeId>545a67b5280e91.42192171</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NC3Rs-CRACK-IT phase 1</gtr:description><gtr:end>2014-06-02</gtr:end><gtr:fundingOrg>National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs)</gtr:fundingOrg><gtr:id>D9C1034C-0CB9-42AC-9F91-4C9A55C301A4</gtr:id><gtr:outcomeId>545a6783d82078.61058075</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2013-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>300000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF MyoD grant</gtr:description><gtr:end>2018-05-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:fundingRef>PG/14/59/31000</gtr:fundingRef><gtr:id>21DD0E12-7B3A-4DFE-9AEA-112F4342A73F</gtr:id><gtr:outcomeId>545a68487de779.98354875</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-05-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>The goal was to develop a novel perfusion system for analysing the response of human embryonic stem cell (hESC) derived cardiomyocytes after challenge with pharmacology and gene knockdown or overexpression. Although the limited time and personnel resources (no staff were funded) on this 18 month proposal restricted completion of some parts of the project, overall we made excellent progress, achieving 8 peer reviewed publications (including Nature Methods and Nature Protocols) and moved towards filing one patent. Thus, the outcomes contributed to UK science by improving scalable methods of hESC culture, differentiation and genetic modification. This enabled sufficient hESC-cardiomyocytes to be produced for proof of principle studies to show that these cells will likely be a valuable tool in large Pharma drug screening and toxicology campaigns.</gtr:description><gtr:exploitationPathways>Commercial utility demonstrated by the follow grant awards, which are partly sponsored by industry:



- BBSRC industrial partnership award with Syngenta. Grant no. BBG021821/1. Stem cell screening of human nutrient-gene interactions at the epigenetic level. 1.8.09-1.7.13. &amp;pound;1.3 million (Co-I)

? SC4SM (Stem Cells for Safer Medicine Government / Private partnership Call). Developing hESC-derived cardiomyocytes as predictors of cardiotoxicity. 1.5.09-1.5.10. &amp;pound;80,000 (PI)

? Bioprocessing Research Industry Club (BRIC) Grant BB/G010390/1. Developing scalable and standardised manufacturing methods for human PSCs. 1.1.09-31.11.12. &amp;pound;900,000 (Co-I)

? Bioprocessing Research Industry Club (BRIC) Grant no. BB/G010285/1. Non-invasive biophotonics tool for phenotypic identification of pluripotent stem cells and their progeny. 1.3.09-1.3.12. &amp;pound;654,201 (Co-I) MEA detection of hESC-cardiomyocyte electrophysiology: We established the first MEA system in the UK for non-invasive, realtime analysis of the electrophysiological responses in hESC-cardiomyocytes. 



Improved hESC culture strategies. Ultimately, we demonstrated the MCT method could support 14 different hESC lines derived in 5 countries, even though the lines were originally cultured in the most diverse conditions available, varying in substrate, passaging method and medium composition (Braam et al., Nature Methods, 2008; Braam et al., Nature Protocols, 2008). 



Scalable hESC culture strategies, relevant to the automation industry (Thomas et al., Biotech &amp;amp; Bioeng 2009)



Transgenic enrichment of hESC-cardiomyocytes: Published in Anderson et al., Molecular Therapy, 2007. Shows the potential of enriched cell populations in drug testing. 



Funding: This grant underpinned other successful awards including:

- British Heart Foundation (A rationale approach to improving and scaling production of hESC-cardiomyocytes; PG/07/092/23722) 

- BBSRC funding (Engineering an in vitro living pump; BB/F020619/1). 

- BBSRC industrial partnership award with Syngenta. Grant no. BBG021821/1. Stem cell screening of human nutrient-gene interactions at the epigenetic level. 1.8.09-1.7.13. &amp;pound;1.3 million (Co-I)

? SC4SM (Stem Cells for Safer Medicine Government / Private partnership Call). Developing hESC-derived cardiomyocytes as predictors of cardiotoxicity. 1.5.09-1.5.10. &amp;pound;80,000 (PI)

? MRC Grant no. 20970. New in vitro models of DMD by induced pluripotency in patient biopsies and gene knockdown in hESCs. 1.1.09-31.9.12. &amp;pound;540,000 (PI)

? Bioprocessing Research Industry Club (BRIC) Grant BB/G010390/1. Developing scalable and standardised manufacturing methods for human PSCs. 1.1.09-31.11.12. &amp;pound;900,000 (Co-I)

? Bioprocessing Research Industry Club (BRIC) Grant no. BB/G010285/1. Non-invasive biophotonics tool for phenotypic identification of pluripotent stem cells and their progeny. 1.3.09-1.3.12. &amp;pound;654,201 (Co-I)</gtr:exploitationPathways><gtr:id>AAE37359-D83F-4CD2-90F0-A50DD60CF277</gtr:id><gtr:outcomeId>r-8741314652.134956776fc2ca</gtr:outcomeId><gtr:sectors><gtr:sector>Healthcare</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Masters course</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>2D0AF800-7E20-4ED3-822B-4D33E603ABAF</gtr:id><gtr:impact>masters levels training in stem cell technologies</gtr:impact><gtr:outcomeId>mH1VLePfr25</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>genome editing techniques and cell lines</gtr:description><gtr:id>B7894DEA-F94B-44EE-AF7D-4FC178AEA757</gtr:id><gtr:impact>developing UK and EU portfolio of research tools and assisting collaborations / grants</gtr:impact><gtr:outcomeId>545a69cfa445e9.86861247</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>genome editing</gtr:title><gtr:type>Cell line</gtr:type><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>93DCE276-BD86-4A39-B75D-2D3ACDF64B63</gtr:id><gtr:title>Common culture conditions for maintenance and cardiomyocyte differentiation of the human embryonic stem cell lines, BG01 and HUES-7.</gtr:title><gtr:parentPublicationTitle>The International journal of developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1dc533ec61bcb06d365d185e0dabeb1f"><gtr:id>1dc533ec61bcb06d365d185e0dabeb1f</gtr:id><gtr:otherNames>Denning C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0214-6282</gtr:issn><gtr:outcomeId>589d8a6b424a77.84620425</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1088C4A5-82A1-4450-A0A4-39AD5D877C86</gtr:id><gtr:title>Identification of polymer surface adsorbed proteins implicated in pluripotent human embryonic stem cell expansion.</gtr:title><gtr:parentPublicationTitle>Biomaterials science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/12624f7c7748d454dbff9720d6c307a4"><gtr:id>12624f7c7748d454dbff9720d6c307a4</gtr:id><gtr:otherNames>Hammad M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2047-4830</gtr:issn><gtr:outcomeId>585d31a4a9e524.86714431</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7BE5F65D-1845-4A04-BED5-B06A016C7F8F</gtr:id><gtr:title>Allele-specific RNA interference rescues the long-QT syndrome phenotype in human-induced pluripotency stem cell cardiomyocytes.</gtr:title><gtr:parentPublicationTitle>European heart journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c737bf77ff2d19310dc6d3e68481b0fd"><gtr:id>c737bf77ff2d19310dc6d3e68481b0fd</gtr:id><gtr:otherNames>Matsa E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0195-668X</gtr:issn><gtr:outcomeId>545a629a1c27f9.53824035</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F8B10324-0B33-42D1-A479-BDC89B88BDD9</gtr:id><gtr:title>Modeling and study of the mechanism of dilated cardiomyopathy using induced pluripotent stem cells derived from individuals with Duchenne muscular dystrophy.</gtr:title><gtr:parentPublicationTitle>Disease models &amp; mechanisms</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6ba577c6d3ec3aa14281199806ff0d41"><gtr:id>6ba577c6d3ec3aa14281199806ff0d41</gtr:id><gtr:otherNames>Lin B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1754-8403</gtr:issn><gtr:outcomeId>566831a30c46a0.92656705</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>94115959-FA92-4042-9DC8-DB8B501214D0</gtr:id><gtr:title>Genetic manipulation of human embryonic stem cells in serum and feeder-free media.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/931796f79d84b0eb5d39b13aed61804f"><gtr:id>931796f79d84b0eb5d39b13aed61804f</gtr:id><gtr:otherNames>Braam SR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>XwQx71juxZE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>33BD5018-6FAB-4E2A-9A0E-92EA6C783492</gtr:id><gtr:title>Automated, scalable culture of human embryonic stem cells in feeder-free conditions.</gtr:title><gtr:parentPublicationTitle>Biotechnology and bioengineering</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a5cf6183ac946ce2727a4beac8290f2e"><gtr:id>a5cf6183ac946ce2727a4beac8290f2e</gtr:id><gtr:otherNames>Thomas RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0006-3592</gtr:issn><gtr:outcomeId>589d8a68ab7673.64812108</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F204798A-DCE4-4391-A8E0-837EDA06B8E3</gtr:id><gtr:title>Noninvasive detection and imaging of molecular markers in live cardiomyocytes derived from human embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Biophysical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f7d7c666e2a413306c117639166665b"><gtr:id>9f7d7c666e2a413306c117639166665b</gtr:id><gtr:otherNames>Pascut FC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-3495</gtr:issn><gtr:outcomeId>pm_13243_23_21190678</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C8DADA88-E481-4BEF-9594-844A56F969DF</gtr:id><gtr:title>Oct4 during the pluripotency differentiation transition: who is regulating the regulator</gtr:title><gtr:parentPublicationTitle>Regenerative Medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/172649dab7a38879608fe1416a9530ec"><gtr:id>172649dab7a38879608fe1416a9530ec</gtr:id><gtr:otherNames>Young L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:outcomeId>589d8a6a9b6af9.54836115</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>50F7DA3B-ED2A-4EAB-A7A7-30E7EA793033</gtr:id><gtr:title>Exon skipping and gene transfer restore dystrophin expression in human induced pluripotent stem cells-cardiomyocytes harboring DMD mutations.</gtr:title><gtr:parentPublicationTitle>Stem cells and development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d0a82c1753617d519e42ca31d6631d0a"><gtr:id>d0a82c1753617d519e42ca31d6631d0a</gtr:id><gtr:otherNames>Dick E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1547-3287</gtr:issn><gtr:outcomeId>589d8a67771875.75144267</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D3C24CAC-C16F-406A-AC47-C60BFADDE891</gtr:id><gtr:title>Non-invasive label-free monitoring the cardiac differentiation of human embryonic stem cells in-vitro by Raman spectroscopy.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f7d7c666e2a413306c117639166665b"><gtr:id>9f7d7c666e2a413306c117639166665b</gtr:id><gtr:otherNames>Pascut FC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>589d8a679219c1.05030904</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>00E6164B-E74B-42CB-B8F9-D0F8405D5843</gtr:id><gtr:title>The patentability of human embryonic stem cells in Europe.</gtr:title><gtr:parentPublicationTitle>Nature biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2507f68508b9290828d51404281e0e33"><gtr:id>2507f68508b9290828d51404281e0e33</gtr:id><gtr:otherNames>Porter G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1087-0156</gtr:issn><gtr:outcomeId>10EFD7FFDF8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BBDBA5CA-FE8A-4D8A-8EAF-76A9DC3B5930</gtr:id><gtr:title>Toward label-free Raman-activated cell sorting of cardiomyocytes derived from human embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Journal of biomedical optics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f7d7c666e2a413306c117639166665b"><gtr:id>9f7d7c666e2a413306c117639166665b</gtr:id><gtr:otherNames>Pascut FC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1083-3668</gtr:issn><gtr:outcomeId>pm_13243_23_21529069</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5CA5ED68-0E4C-42BC-8B8C-A450FBCBDB2F</gtr:id><gtr:title>Current status of drug screening and disease modelling in human pluripotent stem cells.</gtr:title><gtr:parentPublicationTitle>BioEssays : news and reviews in molecular, cellular and developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/295ffa75c27b1791106e9b65b0baa8fc"><gtr:id>295ffa75c27b1791106e9b65b0baa8fc</gtr:id><gtr:otherNames>Rajamohan D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0265-9247</gtr:issn><gtr:outcomeId>pm_13243_23_22886688</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>60F75010-FBBD-4002-BA7C-207440B62D9B</gtr:id><gtr:title>Directed differentiation of human embryonic stem cells to interrogate the cardiac gene regulatory network.</gtr:title><gtr:parentPublicationTitle>Molecular therapy : the journal of the American Society of Gene Therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/774adde14d69c12426f5b7e4aac46b56"><gtr:id>774adde14d69c12426f5b7e4aac46b56</gtr:id><gtr:otherNames>Dixon JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1525-0016</gtr:issn><gtr:outcomeId>pm_13243_23_21694703</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D376DE8E-6881-4E74-967A-059DEA0BAB68</gtr:id><gtr:title>Faster generation of hiPSCs by coupling high-titer lentivirus and column-based positive selection.</gtr:title><gtr:parentPublicationTitle>Nature protocols</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d0a82c1753617d519e42ca31d6631d0a"><gtr:id>d0a82c1753617d519e42ca31d6631d0a</gtr:id><gtr:otherNames>Dick E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1750-2799</gtr:issn><gtr:outcomeId>QyYd3WAdR8P</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8B5D8201-13A4-43A4-9BA5-E12D88275071</gtr:id><gtr:title>Automated Electrophysiological and Pharmacological Evaluation of Human Pluripotent Stem Cell-Derived Cardiomyocytes.</gtr:title><gtr:parentPublicationTitle>Stem cells and development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/295ffa75c27b1791106e9b65b0baa8fc"><gtr:id>295ffa75c27b1791106e9b65b0baa8fc</gtr:id><gtr:otherNames>Rajamohan D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1547-3287</gtr:issn><gtr:outcomeId>589d8a66ee7154.90895501</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DE99CFF2-C2BF-4612-86C0-77ACB8AE8114</gtr:id><gtr:title>Bioluminescence imaging of human embryonic stem cells transplanted in vivo in murine and chick models.</gtr:title><gtr:parentPublicationTitle>Cloning and stem cells</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/39e2fb8c5f522f60194815ba57656b6d"><gtr:id>39e2fb8c5f522f60194815ba57656b6d</gtr:id><gtr:otherNames>Priddle H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1536-2302</gtr:issn><gtr:outcomeId>589d8a68cd3139.85599916</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3B33F8B8-3F3D-41D2-928D-45C2954E974F</gtr:id><gtr:title>In vitro uses of human pluripotent stem cell-derived cardiomyocytes.</gtr:title><gtr:parentPublicationTitle>Journal of cardiovascular translational research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c737bf77ff2d19310dc6d3e68481b0fd"><gtr:id>c737bf77ff2d19310dc6d3e68481b0fd</gtr:id><gtr:otherNames>Matsa E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1937-5387</gtr:issn><gtr:outcomeId>pm_13243_23_22639342</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E0DE5375-4295-4871-94B4-B90CB6EDBD41</gtr:id><gtr:title>Materials for stem cell factories of the future.</gtr:title><gtr:parentPublicationTitle>Nature materials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/71778760bcfbaedc02a6e2939f7135ca"><gtr:id>71778760bcfbaedc02a6e2939f7135ca</gtr:id><gtr:otherNames>Celiz AD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1476-1122</gtr:issn><gtr:outcomeId>545a6299e721e5.09179201</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>105A3117-A1D9-4F30-8848-425D75B661DC</gtr:id><gtr:title>Combined hydrogels that switch human pluripotent stem cells from self-renewal to differentiation.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/774adde14d69c12426f5b7e4aac46b56"><gtr:id>774adde14d69c12426f5b7e4aac46b56</gtr:id><gtr:otherNames>Dixon JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>545a629996af88.73290622</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F805A9D7-EBF0-4A9F-8D16-983A5AACF6F7</gtr:id><gtr:title>Small molecule absorption by PDMS in the context of drug response bioassays.</gtr:title><gtr:parentPublicationTitle>Biochemical and biophysical research communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4fd58851f705a631b75ed1ceded0e823"><gtr:id>4fd58851f705a631b75ed1ceded0e823</gtr:id><gtr:otherNames>van Meer BJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0006-291X</gtr:issn><gtr:outcomeId>589d8a66c8f384.10722477</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3C8DA1FB-2268-4B26-8B33-88938CEDE651</gtr:id><gtr:title>Can Human Pluripotent Stem Cell-Derived Cardiomyocytes Advance Understanding of Muscular Dystrophies?</gtr:title><gtr:parentPublicationTitle>Journal of neuromuscular diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/98adbe4c2a1dde13837d93783963d6c0"><gtr:id>98adbe4c2a1dde13837d93783963d6c0</gtr:id><gtr:otherNames>Kalra S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>58bd8942585926.33175763</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>00C6CD06-57CF-4B3F-A8AB-82E0F120C0F1</gtr:id><gtr:title>Discovery of a Novel Polymer for Human Pluripotent Stem Cell Expansion and Multilineage Differentiation.</gtr:title><gtr:parentPublicationTitle>Advanced materials (Deerfield Beach, Fla.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/71778760bcfbaedc02a6e2939f7135ca"><gtr:id>71778760bcfbaedc02a6e2939f7135ca</gtr:id><gtr:otherNames>Celiz AD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0935-9648</gtr:issn><gtr:outcomeId>566831a2cd0689.40495220</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DC99594C-AFE5-47C0-B93A-EC7DE10FAEE8</gtr:id><gtr:title>Gene-specific vulnerability to imprinting variability in human embryonic stem cell lines.</gtr:title><gtr:parentPublicationTitle>Genome research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/98f52a1e300c8e07792521e8a804088f"><gtr:id>98f52a1e300c8e07792521e8a804088f</gtr:id><gtr:otherNames>Kim KP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1088-9051</gtr:issn><gtr:outcomeId>174FA08A3E0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F8265310-7714-44FD-B2A0-010380861E7F</gtr:id><gtr:title>Scaling human pluripotent stem cell expansion and differentiation: are cell factories becoming a reality?</gtr:title><gtr:parentPublicationTitle>Regenerative medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ee80f93fb699e3ce06d44043a7ef99d"><gtr:id>3ee80f93fb699e3ce06d44043a7ef99d</gtr:id><gtr:otherNames>Smith JG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1746-0751</gtr:issn><gtr:outcomeId>566831a2770099.16364282</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>316A8CBB-6D17-4FD4-9456-C6477457B656</gtr:id><gtr:title>Evaluating the utility of cardiomyocytes from human pluripotent stem cells for drug screening.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d0a82c1753617d519e42ca31d6631d0a"><gtr:id>d0a82c1753617d519e42ca31d6631d0a</gtr:id><gtr:otherNames>Dick E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>Zt3jYrQLivW</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7EBB0E4D-4B19-4557-A396-7B812AA29887</gtr:id><gtr:title>Chemically diverse polymer microarrays and high throughput surface characterisation: a method for discovery of materials for stem cell culture?Electronic supplementary information (ESI) available. See DOI: 10.1039/c4bm00054dClick here for additional data file.</gtr:title><gtr:parentPublicationTitle>Biomaterials science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/71778760bcfbaedc02a6e2939f7135ca"><gtr:id>71778760bcfbaedc02a6e2939f7135ca</gtr:id><gtr:otherNames>Celiz AD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2047-4830</gtr:issn><gtr:outcomeId>545a6299be25e0.66360021</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A586F793-D515-423B-B72B-E368EA7D9B26</gtr:id><gtr:title>Maintenance of pluripotency in human embryonic stem cells cultured on a synthetic substrate in conditioned medium.</gtr:title><gtr:parentPublicationTitle>Biotechnology and bioengineering</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be02904063843eff826855654d7e9247"><gtr:id>be02904063843eff826855654d7e9247</gtr:id><gtr:otherNames>Mahlstedt MM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-3592</gtr:issn><gtr:outcomeId>nMtk949YQyo</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>47FEC29F-7A96-42AD-B212-76FC75882313</gtr:id><gtr:title>Human Embryonic Stem Cells</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d94a6f11d4d6c6086c7e30e210b9cb16"><gtr:id>d94a6f11d4d6c6086c7e30e210b9cb16</gtr:id><gtr:otherNames>Mummery C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:isbn>9780470033562</gtr:isbn><gtr:outcomeId>589d8a6abd9ba1.44794233</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>213599D4-224A-4FB3-A60E-A399D82AE5A2</gtr:id><gtr:title>A defined synthetic substrate for serum-free culture of human stem cell derived cardiomyocytes with improved functional maturity identified using combinatorial materials microarrays.</gtr:title><gtr:parentPublicationTitle>Biomaterials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/15f5a65ec20558965fa2d27363b8d946"><gtr:id>15f5a65ec20558965fa2d27363b8d946</gtr:id><gtr:otherNames>Patel AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0142-9612</gtr:issn><gtr:outcomeId>566831a2a20339.76663919</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3D830ADC-6D34-499B-A2C0-71A5EEDE62CD</gtr:id><gtr:title>Restriction landmark genome scanning identifies culture-induced DNA methylation instability in the human embryonic stem cell epigenome.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/711d7c4345cd767e79003f4e4f4b46d2"><gtr:id>711d7c4345cd767e79003f4e4f4b46d2</gtr:id><gtr:otherNames>Allegrucci C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>52AD4EBFDFE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B74949F1-0307-4D28-AC4A-1DA361E2D69E</gtr:id><gtr:title>Stem cell-derived models to improve mechanistic understanding and prediction of human drug-induced liver injury.</gtr:title><gtr:parentPublicationTitle>Hepatology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7f098469dc1dbb18dc75ff4bb9372c1b"><gtr:id>7f098469dc1dbb18dc75ff4bb9372c1b</gtr:id><gtr:otherNames>Goldring C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0270-9139</gtr:issn><gtr:outcomeId>589d8a675a6da5.27031921</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E894E27F-89D5-400A-8CE9-C46950EA0F7A</gtr:id><gtr:title>5-hydroxymethyl-cytosine enrichment of non-committed cells is not a universal feature of vertebrate development.</gtr:title><gtr:parentPublicationTitle>Epigenetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/554888849f9058347fc5093fe6a0ca4f"><gtr:id>554888849f9058347fc5093fe6a0ca4f</gtr:id><gtr:otherNames>Almeida RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1559-2294</gtr:issn><gtr:outcomeId>pm_13243_23_22419071</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9059A2BC-C18C-4EB1-8272-C841372885FC</gtr:id><gtr:title>Rapid micropatterning of cell lines and human pluripotent stem cells on elastomeric membranes.</gtr:title><gtr:parentPublicationTitle>Biotechnology and bioengineering</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/87660c95d65a3011d13d00df19cbec1f"><gtr:id>87660c95d65a3011d13d00df19cbec1f</gtr:id><gtr:otherNames>Paik I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-3592</gtr:issn><gtr:outcomeId>aBEw2wgMEoi</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>222DB284-FAC1-4EB9-AB09-796F252E51A2</gtr:id><gtr:title>Cardiomyocytes from human pluripotent stem cells: From laboratory curiosity to industrial biomedical platform.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1dc533ec61bcb06d365d185e0dabeb1f"><gtr:id>1dc533ec61bcb06d365d185e0dabeb1f</gtr:id><gtr:otherNames>Denning C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>566831a234bbb9.71328458</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>838895B3-8C7B-4E29-B918-F75446F1E07B</gtr:id><gtr:title>Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation.</gtr:title><gtr:parentPublicationTitle>European heart journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c737bf77ff2d19310dc6d3e68481b0fd"><gtr:id>c737bf77ff2d19310dc6d3e68481b0fd</gtr:id><gtr:otherNames>Matsa E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0195-668X</gtr:issn><gtr:outcomeId>p83MbRqgBzH</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B91F9E92-AC1B-43E7-B1A6-D5D0219EAAC2</gtr:id><gtr:title>Two new protocols to enhance the production and isolation of human induced pluripotent stem cell lines.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d0a82c1753617d519e42ca31d6631d0a"><gtr:id>d0a82c1753617d519e42ca31d6631d0a</gtr:id><gtr:otherNames>Dick E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn><gtr:outcomeId>pm_13243_23_21095172</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F8384241-1C27-4814-821A-620B0B3FD1B9</gtr:id><gtr:title>Transgenic enrichment of cardiomyocytes from human embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Molecular therapy : the journal of the American Society of Gene Therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/25f1d9595d9be968fce9ee3d8dd1e7fc"><gtr:id>25f1d9595d9be968fce9ee3d8dd1e7fc</gtr:id><gtr:otherNames>Anderson D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1525-0016</gtr:issn><gtr:outcomeId>589d8a6aefbc96.03096462</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4720416F-CD3B-4130-B314-0B0E69C87716</gtr:id><gtr:title>Stem Cell Engineering</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/34192f29560b0b65713c54929c16a254"><gtr:id>34192f29560b0b65713c54929c16a254</gtr:id><gtr:otherNames>Kane N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:isbn>978-3-642-11864-7</gtr:isbn><gtr:outcomeId>589d8a68433915.22131110</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C3E15BAF-85EF-465E-A07E-D8E93DDBC52F</gtr:id><gtr:title>Highly efficient delivery of functional cargoes by the synergistic effect of GAG binding motifs and cell-penetrating peptides.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/774adde14d69c12426f5b7e4aac46b56"><gtr:id>774adde14d69c12426f5b7e4aac46b56</gtr:id><gtr:otherNames>Dixon JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>56c49318aea877.58554434</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>97440B65-06B5-4430-A686-C06D7CBDB5C2</gtr:id><gtr:title>Aberrant a-adrenergic hypertrophic response in cardiomyocytes from human induced pluripotent cells.</gtr:title><gtr:parentPublicationTitle>Stem cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44f93743e559aafdfa1e2921addae87e"><gtr:id>44f93743e559aafdfa1e2921addae87e</gtr:id><gtr:otherNames>F?ldes G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2213-6711</gtr:issn><gtr:outcomeId>566831a33a17b5.93053517</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>85715761-49B7-4574-99CA-43214C28DD73</gtr:id><gtr:title>Cardiomyocytes from human embryonic stem cells as predictors of cardiotoxicity</gtr:title><gtr:parentPublicationTitle>Drug Discovery Today: Therapeutic Strategies</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1dc533ec61bcb06d365d185e0dabeb1f"><gtr:id>1dc533ec61bcb06d365d185e0dabeb1f</gtr:id><gtr:otherNames>Denning C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:outcomeId>589d8a690b5747.83103468</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>49A5DC96-4298-4DD0-8611-F8CACCB609A5</gtr:id><gtr:title>Improved human embryonic stem cell embryoid body homogeneity and cardiomyocyte differentiation from a novel V-96 plate aggregation system highlights interline variability.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a0bea90aaf075c744a2fc62a831a6fa5"><gtr:id>a0bea90aaf075c744a2fc62a831a6fa5</gtr:id><gtr:otherNames>Burridge PW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>02D4C73BF8A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7DDDCB75-F756-4DE5-8678-FA4F6865695F</gtr:id><gtr:title>High throughput screening for discovery of materials that control stem cell fate</gtr:title><gtr:parentPublicationTitle>Current Opinion in Solid State and Materials Science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d87383292ff314baabba8e48b3e9fc3a"><gtr:id>d87383292ff314baabba8e48b3e9fc3a</gtr:id><gtr:otherNames>Patel A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>589d8a6718b837.00948576</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EBE87094-E866-4CA4-ABFB-5875340948E1</gtr:id><gtr:title>A multielectrode array (MEA) biochip with excimer laserproduced microwell features</gtr:title><gtr:parentPublicationTitle>Circuit World</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/68809d33eb7e2bf2fd3588f99f6fdd33"><gtr:id>68809d33eb7e2bf2fd3588f99f6fdd33</gtr:id><gtr:otherNames>Flaherty O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>HkqqvgXJFZj</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9342B521-9879-42A3-8B6B-E997FAB8E902</gtr:id><gtr:title>Exon skipping and gene transfer restore dystrophin expression in hiPSC-cardiomyocytes harbouring DMD mutations.</gtr:title><gtr:parentPublicationTitle>Stem cells and development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d0a82c1753617d519e42ca31d6631d0a"><gtr:id>d0a82c1753617d519e42ca31d6631d0a</gtr:id><gtr:otherNames>Dick E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1547-3287</gtr:issn><gtr:outcomeId>545a629a40e395.84709913</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>59680CAE-21AA-4F1B-91F5-4B82F07C7BC3</gtr:id><gtr:title>Improved genetic manipulation of human embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Nature methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/931796f79d84b0eb5d39b13aed61804f"><gtr:id>931796f79d84b0eb5d39b13aed61804f</gtr:id><gtr:otherNames>Braam SR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1548-7091</gtr:issn><gtr:outcomeId>589d8a6a177ac5.11979708</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7B40543F-BCEE-422E-97AC-B89A9379FE7A</gtr:id><gtr:title>Repolarization reserve determines drug responses in human pluripotent stem cell derived cardiomyocytes.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/931796f79d84b0eb5d39b13aed61804f"><gtr:id>931796f79d84b0eb5d39b13aed61804f</gtr:id><gtr:otherNames>Braam SR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn><gtr:outcomeId>pm_13243_23_23089628</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1A898CF3-2835-4584-8FB0-43F0E6E9D8EB</gtr:id><gtr:title>Cardiomyocytes from human embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Handbook of experimental pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2b5628b41fe8d44a70999ab3ab81fe28"><gtr:id>2b5628b41fe8d44a70999ab3ab81fe28</gtr:id><gtr:otherNames>Passier R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0171-2004</gtr:issn><gtr:outcomeId>59BD444CBDD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E2BB54DC-EEA2-45FD-A846-B4D314846E97</gtr:id><gtr:title>Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage.</gtr:title><gtr:parentPublicationTitle>Nature biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ac8dda101d738f96423f3e6d8bd9cce1"><gtr:id>ac8dda101d738f96423f3e6d8bd9cce1</gtr:id><gtr:otherNames>International Stem Cell Initiative</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1087-0156</gtr:issn><gtr:outcomeId>pm_13243_23_22119741</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EE4A64E6-C7CF-417A-82F2-28C5EDF714BD</gtr:id><gtr:title>Feeder-free culture of human embryonic stem cells in conditioned medium for efficient genetic modification.</gtr:title><gtr:parentPublicationTitle>Nature protocols</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/931796f79d84b0eb5d39b13aed61804f"><gtr:id>931796f79d84b0eb5d39b13aed61804f</gtr:id><gtr:otherNames>Braam SR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1750-2799</gtr:issn><gtr:outcomeId>456B5591F18</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F9D25FBE-8B62-4DF9-B78D-8F8EE6AE6609</gtr:id><gtr:title>Derivation and characterisation of the human embryonic stem cell lines, NOTT1 and NOTT2.</gtr:title><gtr:parentPublicationTitle>In vitro cellular &amp; developmental biology. Animal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/39e2fb8c5f522f60194815ba57656b6d"><gtr:id>39e2fb8c5f522f60194815ba57656b6d</gtr:id><gtr:otherNames>Priddle H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1071-2690</gtr:issn><gtr:outcomeId>efsbwKUFgwH</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/E006159/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>